These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19566382)

  • 21. Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo.
    Yadav PN; Kroeze WK; Farrell MS; Roth BL
    J Pharmacol Exp Ther; 2011 Oct; 339(1):99-105. PubMed ID: 21737536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of serotonin transporters by cocaine and meprylcaine through 5-TH2C receptor stimulation facilitates their seizure activities.
    Morita K; Hamamoto M; Arai S; Kitayama S; Irifune M; Kawahara M; Kihira K; Dohi T
    Brain Res; 2005 Sep; 1057(1-2):153-60. PubMed ID: 16125150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation.
    Sprouse JS; Reynolds LS; Braselton JP; Rollema H; Zorn SH
    Neuropsychopharmacology; 1999 Nov; 21(5):622-31. PubMed ID: 10516958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pretreatment with etomidate, ketamine, phenytoin, and phenytoin/midazolam on acute, lethal cocaine toxicity.
    Erdur B; Degirmenci E; Kortunay S; Yuksel A; Seyit M; Ergin A
    Neurol Res; 2012 Dec; 34(10):952-6. PubMed ID: 22989770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute cocaine toxicity: antagonism by agents interacting with adrenoceptors.
    Derlet RW; Albertson TE
    Pharmacol Biochem Behav; 1990 Jun; 36(2):225-31. PubMed ID: 2162541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain.
    Agostinho FR; Scaini G; Ferreira GK; Jeremias IC; Réus GZ; Rezin GT; Castro AA; Zugno AI; Quevedo J; Streck EL
    Brain Res Bull; 2009 Dec; 80(6):337-40. PubMed ID: 19748553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine: palliative medicine update.
    Prommer E
    Am J Hosp Palliat Care; 2013 Feb; 30(1):75-82. PubMed ID: 22495793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical antipsychotics in bipolar depression: potential mechanisms of action.
    Yatham LN; Goldstein JM; Vieta E; Bowden CL; Grunze H; Post RM; Suppes T; Calabrese JR
    J Clin Psychiatry; 2005; 66 Suppl 5():40-8. PubMed ID: 16038601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocaine-conditioned place preference by dopamine-deficient mice is mediated by serotonin.
    Hnasko TS; Sotak BN; Palmiter RD
    J Neurosci; 2007 Nov; 27(46):12484-8. PubMed ID: 18003826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticonvulsant modification of cocaine-induced toxicity in the rat.
    Derlet RW; Albertson TE
    Neuropharmacology; 1990 Mar; 29(3):255-9. PubMed ID: 2325832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against cocaine and combined cocaine-ethanol toxicities in mice by imidazobenzodiazepine Ro 15-4513.
    Hayase T; Yamamoto Y; Yamamoto K
    Toxicology; 1997 Feb; 117(2-3):171-82. PubMed ID: 9057896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.
    Li M; Sun T; Mead A
    J Neural Transm (Vienna); 2012 Apr; 119(4):497-505. PubMed ID: 21986871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of olanzapine on ethanol withdrawal syndrome in rats.
    Unsalan N; Saglam E; Kayir H; Uzbay T
    Eur J Pharmacol; 2008 Jan; 579(1-3):208-14. PubMed ID: 18022155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D₂ but not 5-HT2A/2C bindings in rat brains.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():75-80. PubMed ID: 25149912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New formulations of olanzapine in the treatment of acute agitation].
    Bartkó G
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):171-8. PubMed ID: 17211052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential.
    Maxwell CR; Liang Y; Weightman BD; Kanes SJ; Abel T; Gur RE; Turetsky BI; Bilker WB; Lenox RH; Siegel SJ
    Neuropsychopharmacology; 2004 Apr; 29(4):739-46. PubMed ID: 14735128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct functional profiles of aripiprazole and olanzapine at RNA edited human 5-HT2C receptor isoforms.
    Zhang JY; Kowal DM; Nawoschik SP; Lou Z; Dunlop J
    Biochem Pharmacol; 2006 Feb; 71(4):521-9. PubMed ID: 16336943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex.
    Amargós-Bosch M; Artigas F; Adell A
    Eur J Pharmacol; 2005 Jun; 516(3):235-8. PubMed ID: 15967429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressant drugs appear to enhance cocaine-induced toxicity.
    O'Dell LE; George FR; Ritz MC
    Exp Clin Psychopharmacol; 2000 Feb; 8(1):133-41. PubMed ID: 10743914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.
    Zhang W; Bymaster FP
    Psychopharmacology (Berl); 1999 Jan; 141(3):267-78. PubMed ID: 10027508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.